Literature DB >> 8193535

Oncogenic activation of tyrosine kinases.

G A Rodrigues1, M Park.   

Abstract

Tyrosine kinases comprise the largest group of oncoproteins, a fact that underscores the importance of reversible tyrosine phosphorylation in the regulation of essential cellular functions. Oncogenic activation of tyrosine kinases results in the constitutive activation of what is normally a conditionally regulated enzyme activity. Studies of tyrosine kinase oncoproteins, and a comparison with their corresponding proto-oncogene products, have identified important functional and regulatory domains within these proteins, positive and negative regulators of their enzyme activities and signalling cascades that control cell growth and differentiation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8193535     DOI: 10.1016/0959-437x(94)90086-8

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  18 in total

1.  Multiple SH3 domain interactions regulate NADPH oxidase assembly in whole cells.

Authors:  I de Mendez; A G Adams; R A Sokolic; H L Malech; T L Leto
Journal:  EMBO J       Date:  1996-03-15       Impact factor: 11.598

2.  Oncogenic tyrosine kinases target Dok-1 for ubiquitin-mediated proteasomal degradation to promote cell transformation.

Authors:  Justyna A Janas; Linda Van Aelst
Journal:  Mol Cell Biol       Date:  2011-05-02       Impact factor: 4.272

3.  Activation of the JNK pathway is essential for transformation by the Met oncogene.

Authors:  G A Rodrigues; M Park; J Schlessinger
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

4.  Structural Basis of TPR-Mediated Oligomerization and Activation of Oncogenic Fusion Kinases.

Authors:  Kuntal Pal; Abhishek Bandyopadhyay; X Edward Zhou; Qingping Xu; David P Marciano; Joseph S Brunzelle; Smitha Yerrum; Patrick R Griffin; George Vande Woude; Karsten Melcher; H Eric Xu
Journal:  Structure       Date:  2017-05-18       Impact factor: 5.006

5.  The activation loop tyrosine 823 is essential for the transforming capacity of the c-Kit oncogenic mutant D816V.

Authors:  S Agarwal; J U Kazi; S Mohlin; S Påhlman; L Rönnstrand
Journal:  Oncogene       Date:  2014-12-01       Impact factor: 9.867

6.  Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes.

Authors:  J Schwaller; J Frantsve; J Aster; I R Williams; M H Tomasson; T S Ross; P Peeters; L Van Rompaey; R A Van Etten; R Ilaria; P Marynen; D G Gilliland
Journal:  EMBO J       Date:  1998-09-15       Impact factor: 11.598

7.  Sporadic amplification of the insulin receptor gene in human breast cancer.

Authors:  V Papa; G Milazzo; I D Goldfine; F M Waldman; R Vigneri
Journal:  J Endocrinol Invest       Date:  1997-10       Impact factor: 4.256

8.  Requirements of multiple domains of SLI-1, a Caenorhabditis elegans homologue of c-Cbl, and an inhibitory tyrosine in LET-23 in regulating vulval differentiation.

Authors:  C H Yoon; C Chang; N A Hopper; G M Lesa; P W Sternberg
Journal:  Mol Biol Cell       Date:  2000-11       Impact factor: 4.138

9.  (-)-Epigallocatechin gallate regulates CD3-mediated T cell receptor signaling in leukemia through the inhibition of ZAP-70 kinase.

Authors:  Jung-Hyun Shim; Hong Seok Choi; Angelo Pugliese; Sung-Young Lee; Jung-Il Chae; Bu Young Choi; Ann M Bode; Zigang Dong
Journal:  J Biol Chem       Date:  2008-08-07       Impact factor: 5.157

Review 10.  Proprotein convertases in tumor progression and malignancy: novel targets in cancer therapy.

Authors:  Abdel-Majid Khatib; Géraldine Siegfried; Michel Chrétien; Peter Metrakos; Nabil G Seidah
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.